|By PR Newswire||
|March 25, 2014 10:06 AM EDT||
LONDON, March 25, 2014 /PRNewswire/ --
The trading session on Monday, March 24, 2014 ended on a negative note as the Dow Jones Industrial Average finished at 16,276.69, down 0.16% and the NASDAQ Composite closed at 4,226.39, down 1.18%. The S&P 500 finished the session 0.49% lower at 1,857.44. The losses were broad based as eight out of ten sectors ended the session in negative. The S&P 500 Health Care Sector Index finished the day at 666.18, down 1.41% and the same has fallen by 2.67% in the last one month. Investor-Edge has initiated coverage on the following equities: Quintiles Transnational Holdings Inc. (NYSE: Q), PerkinElmer Inc. (NYSE: PKI), PAREXEL International Corp. (NASDAQ: PRXL) and Charles River Laboratories International Inc. (NYSE: CRL). Free technical research on Q, PKI, PRXL and CRL can be downloaded upon signing up at:
Shares in Quintiles Transnational Holdings Inc. reported a trading volume of 0.54 million shares, as compared with a three months average volume of 0.79 million shares. The stock ended the day at $50.44, down 1.14% and at an intraday range of $50.22 and $51.73. Shares of the company traded at a PE ratio of 26.04. Quintiles Transnational Holdings Inc.'s shares have fallen by 4.32% in the previous three trading sessions and 5.95% in the last one month, while the same have gained 8.85% on YTD basis. The stock is trading above its 200-day moving average. Quintiles Transnational Holdings Inc.'s 50-day moving average of $50.80 is trading above the 200-day moving average of $45.69. Furthermore, the stock is trading at an Relative Strength Index (RSI) of 43.36. Sign up today to read free research on Q at:
On Monday, PerkinElmer Inc.'s stock fell 1.31% to close at $45.07. A total of 1.13 million shares were traded, which is above the three months average volume of 0.98 million. The stock oscillated between $44.50 and $45.85 during the trading session. Shares of the company traded at a PE ratio of 28.82. PerkinElmer Inc.'s shares have fallen by 1.81% in the previous three trading sessions, while the same has gained 2.08% in the last one month and 9.31% on YTD basis. The stock is trading above its 50-day and 200-day moving averages. PerkinElmer Inc.'s 50-day moving average of $44.00 is trading above the 200-day moving average of $38.57. Furthermore, the stock is trading at an RSI of 57.32. Sign up today to read free research on PKI at:
PAREXEL International Corp.'s stock recorded a trading volume of 0.57 million shares, as compared with a three months average volume of 0.54 million shares. The stock ended the day at $53.40, down 2.48% after vacillating between $52.88 and $55.18. Shares of the company traded at a PE ratio of 27.19. PAREXEL International Corp.'s shares have fallen by 6.18% in the previous three trading sessions and 0.06% in the last one month, but they have gained 18.19% on YTD basis. The company's stock is trading above its 50-day and 200-day moving averages. PAREXEL International Corp.'s 50-day moving average of $51.55 is trading above the 200-day moving average of $48.34. Additionally, shares of the company are trading at an RSI of 53.16. Sign up today to read free research on PRXL at:
On Monday, shares in Charles River Laboratories Intl. Inc. finished the session 0.49% lower at $60.53. The stock recorded trading volume of 0.43 million shares as compared to a three months average volume of 0.60 million shares. The stock fluctuated between $59.16 and $61.32 during the session. Shares of the company traded at a PE ratio of 22.77. Charles River Laboratories Intl. Inc.'s stock has fallen by 2.37% in the previous three trading sessions, while the same has gained 2.98% in the last one month and 14.12% on YTD basis. The stock is trading above its 50-day and 200-day moving averages. Charles River Laboratories Intl. Inc.'s 50-day moving average of $58.47 is trading above the 200-day moving average of $50.29. Moreover, the stock is trading at an RSI of 58.20. Sign up today to read free research on CRL at:
1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.
2. Information in this release is fact checked and produced on a best efforts basis and reviewed by Nidhi Vatsal, a CFA charterholder. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.investor-edge.com.
5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.investor-edge.com.
6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.investor-edge.com for consideration.
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Investor-edge. An outsourced research services provider represented by Nidhi Vatsal, CFA, has only reviewed the information provided by Investor-edge in this article or report according to the Procedures outlined by Investor-edge. Investor-edge is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Investor-edge makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Investor-edge is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Investor-edge whatsoever for any direct, indirect or consequential loss arising from the use of this document. Investor-edge expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Investor-edge does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.